Avricore Health (AVCRF) Cash & Equivalents Growth (5y) (2014 - 2026)
Avricore Health (AVCRF) Cash & Equivalents Growth (5y) (2014 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 213.70 Bn | 209.63 Bn | 8.34 Bn |
| 2 | Danaher | 140.15 Bn | 135.80 Bn | 3.61 Bn |
| 3 | Idexx Laboratories | 46.31 Bn | 46.11 Bn | 779.09 Mn |
| 4 | Agilent Technologies | 39.74 Bn | 37.93 Bn | 990.00 Mn |
| 5 | Iqvia Holdings | 39.38 Bn | 37.30 Bn | 1.44 Bn |
| 6 | Natera | 38.78 Bn | 37.68 Bn | 696.04 Mn |
| 7 | Illumina | 29.96 Bn | 28.79 Bn | 770.00 Mn |
| 8 | Mettler Toledo International | 28.60 Bn | 28.55 Bn | 650.22 Mn |
| 9 | Quest Diagnostics | 26.26 Bn | 25.64 Bn | 1.03 Bn |
| 10 | Avricore Health | 3.04 Mn | 3.01 Mn | -6,202.70 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -40.96% |
| Dec 31, 2025 | -6.78% |
| Sep 30, 2025 | 68.32% |
| Jun 30, 2025 | 31.26% |
| Mar 31, 2025 | 22.02% |
| Dec 31, 2024 | 138.74% |
| Sep 30, 2024 | 65.96% |
| Jun 30, 2024 | 79.82% |
| Dec 31, 2023 | 26.00% |
| Dec 31, 2022 | 0.74% |
| Sep 30, 2022 | 61.52% |
| Jun 30, 2022 | 20.44% |
| Mar 31, 2022 | 29.87% |
| Dec 31, 2021 | 37.88% |
| Sep 30, 2021 | 21.67% |
| Jun 30, 2021 | 14.87% |
| Mar 31, 2021 | 11.44% |
| Dec 31, 2020 | -32.03% |
| Sep 30, 2020 | -55.75% |
| Jun 30, 2020 | -40.98% |